We structurally characterized the adducts of the catalytic domain of matrix metalloproteinase-3 (MMP3) with three different nonpeptidic inhibitors by solving the solution structure of one adduct (MMP3-N-isobutyl-N - (4-methoxyphenylsulfonyl) glycyl hydroxamic acid) and then by calculating structural models of the other two adducts using a reduced set of experimental NMR data , following a recently proposed procedure (Bertini et al.
We have discovered nonpeptidic MMP inhibitors with improved properties , and report here the crystal structures of human stromelysin-1 catalytic domain (SCD) complexed with four of these inhibitors.
We used X-ray crystallography to determine two structures of the catalytic domain of human PARP2 : the complexes with PARP inhibitors 3-aminobenzamide and ABT-888.